Basket Trials (as of April 2019)

ENGOT-GYN1/NCRI/ATARI

Leading group: NCRI

Clinical Trial Study: ATARI Trial: ATr inhibitor in combination with olaparib in gynaecological cancers with ARId1A loss or no loss  

Number of patients accrued: 0

Planned number of patients: 116

Participating groups: 

GINECO, Princes Margaret Consortium Canada

 

Planned start in 2Q  2019

 

Up Coming ENGOT Meeting

Vincci Soma Hotel, Madrid, Spain

October 17-18, 2019

Don't miss out on the latest updates

Save the Date!

You May Also Like

GCA6

GCA WORKSHOPS

Watch the Webcasts 

 

Read More

background

CLINICAL TRIALS

Latest Published Research

 

Read More

patient2

FOR PATIENTS

Key Insights

 

Read More

Athens_logo

ESGO 2019 Congress

ESGO 2019 Athen Congress

 

Read More